Royal Bank Of Canada Issues Pessimistic Forecast for Amrize (NYSE:AMRZ) Stock Price

Amrize (NYSE:AMRZ) had its target price cut by stock analysts at Royal Bank Of Canada from $61.00 to $60.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage presently has a “sector perform” rating on the stock. Royal Bank Of Canada’s target price would suggest a potential upside of 12.78% from the stock’s current price.

AMRZ has been the subject of a number of other research reports. Berenberg Bank set a $70.00 target price on shares of Amrize in a research report on Thursday, February 19th. Citigroup lifted their target price on shares of Amrize from $63.00 to $67.00 and gave the stock a “buy” rating in a research report on Thursday, January 8th. Wall Street Zen raised shares of Amrize from a “sell” rating to a “hold” rating in a research report on Sunday, March 1st. Truist Financial boosted their price objective on shares of Amrize from $60.00 to $75.00 and gave the company a “buy” rating in a research report on Friday, February 20th. Finally, Oppenheimer set a $68.00 price objective on shares of Amrize in a research report on Friday. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $65.00.

Amrize Price Performance

AMRZ stock traded down $0.58 during trading on Friday, reaching $53.20. 1,063,944 shares of the company were exchanged, compared to its average volume of 3,208,296. The company has a market cap of $29.42 billion and a P/E ratio of 25.47. Amrize has a 52-week low of $44.12 and a 52-week high of $65.94. The stock’s 50 day moving average price is $57.86 and its 200 day moving average price is $54.87. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.10 and a current ratio of 1.64.

Amrize (NYSE:AMRZ) last released its quarterly earnings data on Wednesday, April 29th. The company reported ($0.16) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). The company had revenue of $2.18 billion for the quarter. Amrize had a return on equity of 9.88% and a net margin of 9.70%.The company’s quarterly revenue was up 4.7% on a year-over-year basis. As a group, analysts predict that Amrize will post 2.76 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, insider Mario Gross acquired 3,200 shares of the business’s stock in a transaction dated Friday, March 13th. The stock was acquired at an average price of $55.29 per share, with a total value of $176,928.00. Following the completion of the transaction, the insider directly owned 30,947 shares in the company, valued at approximately $1,711,059.63. This represents a 11.53% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Ian A. Johnston bought 4,250 shares of the stock in a transaction that occurred on Tuesday, March 10th. The stock was bought at an average price of $58.94 per share, with a total value of $250,495.00. Following the completion of the acquisition, the chief financial officer owned 25,110 shares of the company’s stock, valued at $1,479,983.40. This trade represents a 20.37% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders have acquired 77,834 shares of company stock valued at $4,511,344. 0.54% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Amrize

A number of institutional investors have recently bought and sold shares of AMRZ. Geode Capital Management LLC purchased a new stake in Amrize in the second quarter valued at approximately $265,000. M&T Bank Corp purchased a new stake in Amrize in the second quarter valued at approximately $205,000. Arrowstreet Capital Limited Partnership purchased a new stake in Amrize in the second quarter valued at approximately $3,870,000. Gabelli Funds LLC purchased a new stake in Amrize in the second quarter valued at approximately $1,083,000. Finally, AXA S.A. purchased a new stake in Amrize in the second quarter valued at approximately $1,065,000.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.